For type 2 diabetes, GLP-1 receptor agonists may be added to metformin when glucose control is inadequate according to NICE guideline NG28
Mounjaro is often used to treat type 2 diabetes because it controls blood sugar by improving insulin sensitivity and enhancing the release of insulin in the body
This means there is no established direct causal relationship between semaglutide and leg cramps based on current regulatory documentation
This indicates that DA-CH5 has a greater comprehensive advantage and more optimal target sites, making it more likely to be used clinically in the future compared to DA-JC4 and DA-JC1
Clinical data shows average A1C reduction of 2.02% in participants with diabetes, triglyceride reduction of 28%, systolic blood pressure reduction of 6.8mmHg, and LDL cholesterol reduction of 12%
For individuals on Ozempic, maintaining adequate fluid intake is essential